Harry Stylli is the founder of Progenity. Progenity has raised $217M in total funding. Latest round: Series B. Backed by Athyrium Capital Management.
Harry Stylli is the founder of Progenity, a biotechnology company based in San Diego, United States. He established the company in 2011 to advance precision medicine in prenatal women's health and gastrointestinal diseases. Progenity has successfully raised $216.63 million across nine funding rounds.
Full founder directory · Investor directory · Company funding database · Fundraising library